These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 9493603

  • 1. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 2. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I, Finkle CD, Winocour PD.
    Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin.
    McBane RD, Hassinger NL, Mruk JS, Grill DE, Chesebro JH.
    Thromb Res; 2005 Jul; 116(6):525-32. PubMed ID: 16181988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN, Girard D, Lochot S, Lecoffre C.
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [Abstract] [Full Text] [Related]

  • 15. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Garcia DA, Baglin TP, Weitz JI, Samama MM.
    Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
    [Abstract] [Full Text] [Related]

  • 16. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
    Cho JH, Yun CH, Seo HS, Koga T, Dan T, Koo BA, Kim HY.
    Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis.
    McClanahan TB, Ignasiak DP, Juneau P, Finkle C, Winocour PD, Gallagher KP.
    J Thromb Thrombolysis; 1999 Jun; 7(3):301-6. PubMed ID: 10375391
    [Abstract] [Full Text] [Related]

  • 18. Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
    Gustafsson D, Elg M, Lenfors S, Börjesson I, Teger-Nilsson AC.
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):69-79. PubMed ID: 8845466
    [Abstract] [Full Text] [Related]

  • 19. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN, Girard D, Girardot C, Lochot S, Lunven C, Visconte C.
    Semin Thromb Hemost; 1996 Jan; 22(3):233-41. PubMed ID: 8836007
    [Abstract] [Full Text] [Related]

  • 20. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P, Pérez-Villa F, Waters D, Lespérance J, Shabani F, Bonan R.
    Circulation; 1995 Apr 15; 91(8):2132-9. PubMed ID: 7697841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.